Cell membrane phospholipids and associated signaling pathways

Cell membrane phospholipids are fundamental structural components of the cellular lipid bilayer that also function as critical precursors for intracellular signaling molecules. These lipids, such as phosphatidylinositol and sphingomyelin, are metabolized by specific enzymes like phospholipases, lipid kinases, and phosphatases to generate secondary messengers including inositol trisphosphate (IP3), diacylglycerol (DAG), and phosphatidylinositol-3,4,5-trisphosphate (PIP3) [1, 2]. These messengers orchestrate a wide array of biological functions, including cell growth, survival, motility, and vesicular trafficking, primarily through the activation of downstream effectors like Protein Kinase B (Akt) and Protein Kinase C (PKC) [3]. Aberrant phospholipid signaling is implicated in numerous pathologies, most notably in oncology, where mutations in the PI3K/Akt pathway drive tumorigenesis, and in inflammatory diseases where arachidonic acid release leads to pro-inflammatory eicosanoid production [4]. Pharmacological intervention typically targets the enzymes regulating these pathways, such as PI3K inhibitors (e.g., alpelisib) or phospholipase A2 inhibitors, though direct modulation of membrane composition using phospholipid analogues like miltefosine is also utilized in treating infections and certain cancers [5, 6]. Sources: [1] Vance, J. E., & Vance, D. E. (2008). Biochemistry of Lipids, Lipoproteins and Membranes. Elsevier. [2] Balla, T. (2013). Phosphoinositides: Tiny lipids with giant roles in cell regulation. Physiological Reviews. [3] Manning, B. D., & Toker, A. (2017). AKT/PKB Signaling: Navigating the Network. Cell. [4] Fruman, D. A., et al. (2017). The PI3K Pathway in Human Disease. Cell. [5] Dorlo, T. P., et al. (2012). Miltefosine: a review of its pharmacology and therapeutic efficacy. Journal of Antimicrobial Chemotherapy. [6] Sun, Y., et al. (2020). Phospholipids and Cancer. Frontiers in Oncology.

Other names

Membrane lipid signalingPhospholipid signaling systemPhosphoinositide signaling pathwayGlycerophospholipid metabolism

Inhibition of lipid kinases (e.g., PI3K), modulation of phospholipase activity, competitive inhibition of phospholipid-dependent signaling, and direct alteration of membrane lipid composition.